References
- Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002; 38: 881–885
- Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565–568
- Folkard S G, Westwick J, Millar A B. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J 1997; 10: 2097–2104
- Kim Y, Sung S S, Kuziel W A, Feldman S, Fu S M, Rose C E, Jr. Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2). J Immunol 2001; 166: 5183–5192
- Alam R, York J, Boyars M, Grant J A, Lee J, Forsythe P, et al. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996; 153: 1398–1404
- Campbell E M, Charo I F, Kunkel S L, Strieter R M, Boring L, Gosling J, et al. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J Immunol 1999; 163: 2160–2167
- Keszei M, Nagy A, Kozma G T, Radosits K, Tölgyesi G, Falus A, Szalai C. Pediatric asthmatic patients have low serum levels of monocyte chemoattractant protein-1. J Asthma 2006; 43: 399–404
- Grob M, Schmid-Grendelmeier P, Joller-Jemelka H I, Ludwig E, Dubs R W, Grob P J, et al. Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma. Allergy 2003; 58: 239–245
- Szalai C, Kozma G T, Nagy A, Bojszkó A, Krikovszky D, Szabó T, et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001; 108: 375–381
- Rovin B H, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259: 344–348
- Yao T C, Wu K C, Chung H T, Shaw C K, Kuo M L, Wu C J, et al. MCP-1 gene regulatory region polymorphism in Chinese children with mild, moderate and near-fatal asthma. Allergy 2004; 59: 436–441
- Global strategy for asthma management and prevention. National Institute of Health. National Heart, Lung, and Blood Institute. U.S. Department of Health and Human Services, Bethesda, MD 2002, NHLBI/WHO Workshop Report. NIH Publication No. 02-3659
- Chihara J, Yasuba H, Tsuda A, Urayama O, Saito N, Honda K, et al. Elevation of the plasma level of RANTES during asthma attacks. J Allergy Clin Immunol 1997; 100: S52–55
- Sousa A R, Lane S J, Nakhosteen J A, Yoshimura T, Lee T H, Poston R N. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 1994; 10: 142–147
- Holgate S T, Bodey K S, Janezic A, Frew A J, Kaplan A P, Teran L M. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997; 156: 1377–1383
- Lummus Z L, Alam R, Bernstein J A, Bernstein D I. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998; 102: 265–274
- Bernstein D I, Cartier A, Côté J, Malo J-L, Boulet L-P, Wanner M, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 2002; 166: 445–450
- Ko F W, Lun S W, Wong C K, Szeto C C, Lam C W, Leung T F, et al. Decreased T-bet expression and changes in chemokine levels in adults with asthma. Clin Exp Immunol 2007; 147: 526–532
- Tillie-Leblond I, Hammad H, Desurmont S, Pugin J, Wallaert B, Tonnel A B, et al. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment. Am J Respir Crit Care Med 2000; 162: 586–592
- Hall D J, Bates M E, Guar L, Cronan M, Korpi N, Bertics P J. The role of p38 MAPK in rhinovirus-induced monocyte chemoattractant protein-1 production by monocytic-lineage cells. J Immunol 2005; 174: 8056–8063
- Cevit O, Kendirli S G, Yilmaz M, Altintas D U, Karakoc G B. Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children. J Investig Allergol Clin Immunol 2007; 17: 286–291
- Hsieh K H, Chou C C, Chiang B L. Immunotherapy suppresses the production of monocyte chemotactic and activating factor and augments the production of IL-8 in children with asthma. J Allergy Clin Immunol 1996; 98: 580–587